133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
4 November 2021
T+64 4 496 2000
Matthew Shaw
By email: [FYI request #16897 email]
Ref:
H202113747
Tēnā koe Matthew
Response to your request for official information
Thank you for your request under the Official Information Act 1982 (the Act), transferred to the
Ministry of Health (the Ministry) on 6 October 2021, for information related to COVID-19 cases
in Managed Isolation and Quarantine (MIQ) facilities from 1 June 2021 to 31 August 2021. I will
respond to each part of your request in turn.
What is the total number of returnees through MIQ over the period?
A total of 26,053 returnees arrived in MIQ during the requested period. Please note that this
number excludes air crew and community arrivals.
- What is the total number of positive cases of COVID-19 identified through MIQ over the
period?
A total of 286 returnees tested positive during this time.
- Of the returnees who tested positive, what was their country of origin? If you do not have
complete records I would accept partial records.
Information on the departure country of returnees who tested positive while in MIQ is included in
the table below.
Departure country
Number of returnees who tested
positive while in MIQ
India
29
Philippines
23
Indonesia
22
Malaysia
21
Fiji
15
United Kingdom
15
United Arab Emirates
14
Russia
13
United States of America
10
Afghanistan
9
Singapore
9
Australia
8
South Africa
7
Other (Countries with less than 7 cases)
91
Total
286
- Of the returnees who tested positive, how many were deemed to be a historical case
and therefore did not require transfer to a quarantine facility?
66 cases were identified as historic cases. All of these were transferred to a quarantine facility.
- Of the returnees who tested positive, from which testing day was their positive result
returned?
Information on the day each case tested positive is included in the table below.
Day of positive test
Number of cases
Day 0
104
Day 3
57
Day 6
19
Day 12
29
Other
77
Total
286
- Of the total number of returnees, how many are fully vaccinated against COVID-19? I
would like this information broken down by vaccine type. If you do not have complete
records I would accept partial records.
Information on vaccination status of returnees is available from 24 August 2021. Therefore, the
Ministry is providing the following information on vaccination and positive cases for MIQ
returnees from 24 August 2021 to 25 October 2021.
Vaccination status
Number of returnees
% of all returnees
Full
11412
67.8
Partial
616
3.7
Unvaccinated
2330
13.9
Unknown
437
2.6
Ineligible because under 12
2026
12.0
Total
16821
100.0
A further breakdown of vaccine type for fully vaccinated returnees is included in the table below.
First vaccine name
Number of fully vaccinated returnees
AstraZeneca / Covishield
2272
CoronaVac
238
CoVaxin
74
Janssen
355
Moderna
818
Novavax
41
Pfizer/BioNtech
7087
Sinopharm
384
Sputnik V
143
Total
11412
Page 2 of 3
- Of the vaccinated returnees, how many have subsequently tested positive for COVID-
19? I would like this information broken down by acute and historical.
Information on the percentage of returnees who subsequently tested positive for COVID-19 is
included in the below table. Please note that this excludes historical cases, as it cannot be
confirmed whether their vaccination occurred prior to their infection.
Number of
% who subsequently tested
Vaccination status
returnees
positive for COVID-19
Full
11412
0.23
Partial
616
0.49
Unvaccinated
2330
0.99
Unknown
437
0
Ineligible because under 12
2026
0.49
I trust this information fulfils your request. Under section 28(3) of the Act you have the right to
ask the Ombudsman to review any decisions made under this request. The Ombudsman may
be contacted by email at:
[email address] or by calling 0800 802 602.
Please note that this response, with your personal details removed, may be published on the
Ministry website at:
www.health.govt.nz/about-ministry/information-releases/responses-official-
information-act-requests. Nāku noa, nā
Gill Hall
Group Manager, COVID-19 Science and Insights
COVID-19 Health System Response
Page 3 of 3
